Scientific activity and scientific production
"Cima's scientific activity has generated publications in journals of high scientific impact, patented biomedical inventions and coordination in international projects."
GLORIA GONZÁLEZ ASEGUINOLAZA
DEPUTY DIRECTOR. CIMA UNIVERSIDAD DE NAVARRA
158
scientific publications
in the first quartile
8,833
impact factor
medium
9,152
average impact factor
with authorship
Our results in high impact journals
Outstanding scientific publications
Year 2019
|
Attal, M. et al. Lancet. 2019 Dec 7;394(10214):2096-2107. |
|
|
| Perez- Ruiz, E. et al. Nature. 2019 May;569(7756):428-432. Immunology and Immunotherapy Program Impact factor: 42.778
|
|
|
| Benechet, AP. et al. Nature 2019. Oct;574(7777):200-205. Gene Therapy and Regulation of Gene Expression Program Impact factor: 42.778
|
| Richardson, PG. et al. Lancet Oncology 2019. Jun;20(6):781-794 Hemato-oncology Program Impact factor: 33.752
|
|
|
| Segovia, C. et al. Nature Medicine 2019. Jul;25(7):1073- 1081. Hemato-oncology Program Impact factor: 36.130
|
|
|
| Melero I et al. Nature Medicine 2019. Mar;25(3):470-476. Immunology and Immunotherapy Program Impact factor: 36.130
|
|
|
| Swarup, V. et al. Nature Medicine 2019. Jan;25(1):152-164. Neuroscience Program Impact factor: 36.130
|
| Kim, JW. et al. Nature Medicine 2019. Nov;25(11):1783- 1795. Collaboration Dr. Vicent Solid Tumor Program Impact factor: 36.130
|
|
|
| Berraondo, P. et al. Cancer Discovery 2019. Aug;9(8):1003- 1005 Editorial Material. Immunology and Immunotherapy Program Impact factor: 29.497
|
|
|
| Etxeberria, I. et al. Cancer Cell 2019. Dec 9;36(6):613-629.e7 Immunology and Immunotherapy Program Impact factor: 26.602
|
|
|
| Rodriguez-Ruiz, ME. et al. Nature Immunology. Doi: 10.1038/ s41590-019-0561-4. Epub 2019 Dec 23. Immunology and Immunotherapy Program Impact factor: 20.479 |
|
|
|
Mastellos, et al. Nature Immunology 2019 Nov;20(11):1556. Editorial Material.
|
| Díez J et al. European Heart Journal 2019. Mar 21;40(12):979-981 Editorial Material. Cardiovascular Disease Program Impact factor: 22.673 |
|
|
| Ravassa, S. et al. Journal of the American College of Cardiology 2019. Apr 2;73(12):1398-1410 Cardiovascular Disease Program Impact factor: 20.589 |
| Berraondo, P. et al. Gut. 2019 Jul;68(7):1323-133 Immunology and Immunotherapy Program Impact factor: 19.819 |
Scientific activity of the
Cima Universidad de Navarra
Latest scientific publications
- Single-Cell RNA-seq Analysis Reveals a Crucial Role for Collagen Triple Helix Repeat Containing 1 (CTHRC1) Cardiac Fibroblasts after Myocardial Infarction Jun 25, 2021 | Magazine: Hepatology
- Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant May 21, 2021 | Magazine: Blood Cancer Journal
- Intratumoural administration and tumour tissue targeting of cancer immunotherapies May 18, 2021 | Magazine: Nature Reviews. Clinical Oncology
- Immunological Biomarkers of Fatal COVID-19: A Study of 868 Patients May 3, 2021 | Magazine: Frontiers in Immunology